Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Lewis

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|September 23, 1998
Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structureD F Lewis, P Lee-Robichaud
Drug Metabolism and Drug Interactions|January 17, 2002
Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolismD F Lewis, S Modi, M Dickins
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylaminesD F Lewis, J Arendt, J English
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 1, 1993
Computer modelling in predicting carcinogenicityC Ioannides, D F Lewis, D V Parke
Chemico-Biological Interactions|January 1, 1989
Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobioticsD F Lewis, C Ioannides, D V Parke
Mutation Research|June 19, 1998
Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogeneticsD F Lewis, E Watson, B G Lake
Mutation Research|March 21, 1998
Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicalsD F Lewis, C Ioannides, D V Parke
Journal of Enzyme Inhibition|August 13, 1999
Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivativesD F Lewis, A Wiseman, M H Tarbit
Human & Experimental Toxicology|November 20, 1998
A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studiesD F Lewis, C Ioannides, D V Parke
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1994
The use of computers in the safety evaluation of drugs and other chemicalsC Ioannides, D F Lewis, D V Parke
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Steroid Biochemistry and Molecular Biology|September 23, 1998
Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structureD F Lewis, P Lee-Robichaud
Drug Metabolism and Drug Interactions|January 17, 2002
Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolismD F Lewis, S Modi, M Dickins
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylaminesD F Lewis, J Arendt, J English
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 1, 1993
Computer modelling in predicting carcinogenicityC Ioannides, D F Lewis, D V Parke
Chemico-Biological Interactions|January 1, 1989
Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobioticsD F Lewis, C Ioannides, D V Parke
Mutation Research|June 19, 1998
Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogeneticsD F Lewis, E Watson, B G Lake
Mutation Research|March 21, 1998
Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicalsD F Lewis, C Ioannides, D V Parke
Journal of Enzyme Inhibition|August 13, 1999
Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivativesD F Lewis, A Wiseman, M H Tarbit
Human & Experimental Toxicology|November 20, 1998
A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studiesD F Lewis, C Ioannides, D V Parke
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1994
The use of computers in the safety evaluation of drugs and other chemicalsC Ioannides, D F Lewis, D V Parke
Pageof 18